A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (nd... von Hamid, R, Loveman, C, Millen, J, Colayco, D, Stanisic, S, Gultyaev, D

Volltext

PCN135 ECONOMIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCER von Lee, C.T, Globe, D, Colayco, D, Gilmore, A, Bramley, T

Volltext

PCN134 HUMANISTIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) von Barocas, D.A, Globe, D, Colayco, D, Gilmore, A, Bramley, T

Volltext

PMU67 IMPACT OF PHARMACIST-PROVIDED TRANSITION OF CARE SERVICES ON HOSPITAL READMISSIONS von Xuan, S., Colayco, D., Hashimoto, J., Komoto, K., McCombs, J.S.

Volltext

PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY von Globe, D, Carlson, J, Patel, H, Colayco, D, Hansen, R.N, Watanabe, J, Sullivan, S.D

Volltext

Impact of an Ambulatory Care Pharmacy-Based Transition of Care Program on Hospital Readmissions and Cost von Ni, W, Colayco, D, Hashimoto, J, Komoto, K, Gowda, C, Wearda, B, McCombs, J

Volltext

PHS107 - Impact of an Ambulatory Care Pharmacy-Based Transition of Care Program on Hospital Readmissions and Cost von Ni, W, Colayco, D, Hashimoto, J, Komoto, K, Gowda, C, Wearda, B, McCombs, J

Volltext

PND29 - Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States von Carlson, J.J., Hansen, R.N., Dmochowski, R., Globe, D., Colayco, D., Sullivan, S.D.

Volltext

PDB1 ASSOCIATION BETWEEN GLYCOSYLATED HEMOGLOBIN AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A NESTED CASE-CONTROL STUDY von Colayco, D, Cheetham, CT, Niu, F, McCombs, J

Volltext

Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11 von Li, Jing, Yakushi, Tanya, Parlati, Francesco, Mackinnon, Andrew L, Perez, Christian, Ma, Yuyong, Carter, Kyle P, Colayco, Sharon, Magnuson, Gavin, Brown, Brock, Nguyen, Kevin, Vasile, Stefan, Suyama, Eigo, Smith, Layton H, Sergienko, Eduard, Pinkerton, Anthony B, Chung, Thomas D Y, Palmer, Amy E, Pass, Ian, Hess, Sonja, Cohen, Seth M, Deshaies, Raymond J

Volltext

Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme von Li, Yi-Jia, Du, Li, Wang, Jianghai, Vega, Ramir, Lee, Terry D., Miao, Yunan, Aldana-Masangkay, Grace, Samuels, Eric R., Li, Baozong, Ouyang, S. Xiaohu, Colayco, Sharon A., Bobkova, Ekaterina V., Divlianska, Daniela B., Sergienko, Eduard, Chung, Thomas D.Y., Fakih, Marwan, Chen, Yuan

Volltext

Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States von Carlson, Josh J., PhD, Hansen, Ryan N., PharmD, PhD, Dmochowski, Roger R., MD, Globe, Denise R., PhD, Colayco, Danielle C., PharmD, MS, Sullivan, Sean D., PhD

Volltext

Inhibition of Hematopoietic Protein Tyrosine Phosphatase Augments and Prolongs ERK1/2 and p38 Activation von Sergienko, Eduard, Xu, Jian, Liu, Wallace H, Dahl, Russell, Critton, David A, Su, Ying, Brown, Brock T, Chan, Xochella, Yang, Li, Bobkova, Ekaterina V, Vasile, Stefan, Yuan, Hongbin, Rascon, Justin, Colayco, Sharon, Sidique, Shyama, Cosford, Nicholas D. P, Chung, Thomas D. Y, Mustelin, Tomas, Page, Rebecca, Lombroso, Paul J, Tautz, Lutz

Volltext

Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids von Bobkova, Ekaterina V, Liu, Wallace H, Colayco, Sharon, Rascon, Justin, Vasile, Stefan, Gasior, Carlton, Critton, David A, Chan, Xochella, Dahl, Russell, Su, Ying, Sergienko, Eduard, Chung, Thomas D. Y, Mustelin, Tomas, Page, Rebecca, Tautz, Lutz

Volltext